SCHEMBL6365364

SCHEMBL6365364

CCCSc1cccc2c1C(=O)c1cccc(SCCC)c1C2=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SOAT1 P35610 8/20 0.47
▸ MAPT P10636 3/20 0.43
▸ MAPK1 P28482 3/20 0.43
▸ NSD2 O96028 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ PTGS2 P35354 1/20 0.42
▸ STAT3 P40763 1/20 0.40
▸ MAOA P21397 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ FGB P02675 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ HTR7 P34969 1/20 0.39
▸ P4HB P07237 1/20 0.38
▸ S100A4 P26447 2/20 0.38
▸ PDE5A O76074 2/20 0.38
▸ EGFR P00533 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ PABPC1 P11940 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7855715 0.86 SOAT1 (0.52) SOAT1PTGS2P4HBS100A4
SCHEMBL14580986 0.85 SOAT1 (0.56) SOAT1MAPTMAPK1KDM4EPTGS2
SCHEMBL10581743 0.85 SOAT1 (0.54) SOAT1MAPTMAPK1NSD2KDM4E
SCHEMBL6365511 0.85 S100A4 (0.47) SOAT1MAPTMAPK1NSD2KDM4E
SCHEMBL9017718 0.84 SOAT1 (0.49) SOAT1MAPTMAPK1NSD2KDM4E
SCHEMBL10894890 0.84 SOAT1 (0.55) SOAT1MAPTMAPK1NSD2KDM4E
SCHEMBL23388947 0.82 SOAT1 (0.56) SOAT1MAPTMAPK1NSD2KDM4E
SCHEMBL29886439 0.82 SOAT1 (0.56) SOAT1MAPTMAPK1NSD2KDM4E
SCHEMBL6374043 0.81 MAPT (0.55) MAPTMAPK1NSD2KDM4ESTAT3
SCHEMBL11391072 0.81 SOAT1 (0.44) SOAT1MAPK1PTGS2HTR7P4HB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009924-A1 Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives HUANG HSU-SHAN (TW) 2005-01-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009924-A1 Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives NFE2L2, NR2F2, TFAM SOAT1 2722/4885MAPT 4766/4885MAPK1 4421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback